Ultralife (NASDAQ: ULBI) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.15 by 120 percent. This is a 123.08 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $47.445 million which missed the analyst consensus estimate of $52.400 million by 9.46 percent. This is a 6.50 percent decrease over sales of $50.746 million the same period last year.